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ABSTRACT 
BACKGROUND: Exercise induced bronchoconstriction (EIB) affects a large number of 
athletes, with rates within literature between 7% to 50% for elite athletes (Dickinson et 
al., 2006; Falvey et al., 2010). Two provocation methods for the diagnosis of EIB include 
an exercise challenge test (ECT) and a eucapnic voluntary hyperpnoea (EVH) test. 
Previous research has compared the airway response to ECT to EVH but has often failed 
to ensure that the ECT is conducted according to standardised guidelines (ATS., 1999; 
Trumper et al., 2009; Stickland et al., 2010). PURPOSE: Therefore, the aim of this study 
was to compare the airway responses to ECT and EVH following standardised 
guidelines. METHODS: In a randomised order and on separate days, seventeen 
participants completed an ECT and an EVH test. Participants were all University level 
athletes or professional rugby league player (Age 25 ± 2 yr.; height 1.81 ± 0.06 m; mass 
85.4 ± 13.7 kg) recruited via open enquiry to the study. The ECT procedure followed the 
American Thoracic Society (ATS) protocol, whilst the EVH test followed the procedures 
recommended by Anderson et al. (2001). Spirometry was performed prior to and at 0, 3, 
5, 10, 15, 20, and 30 min post challenge. A positive EIB diagnosis was regarded as a 
≥10% decrease in forced expired ventilation over one second (FEV1). RESULTS: Nine 
participants experienced a fall in FEV1 ≥10%, with five having falls ≥10% in both 
provocation tests. Two participants experienced falls in the ECT alone and EVH alone 
respectively. Out of the nine participants, only two had a previous history of asthma. 
There was no significant difference in the peak ΔFEV1 between the two provocation tests 
(p=0.143). CONCLUSION: In summation, athletes should be tested for EIB, with both 
the ECT and EVH being acceptable methods, although our results are inconclusive due 
to poor agreement and limitations. Future research should aim to have a greater number 
of participants. 
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Asthma is regarded as a highly prevalent chronic inflammatory disease, characterised 
by intermittent airway obstruction, causing breathlessness, wheezing and coughing. 
(Curran et al., 2010). Asthma is a common diagnosis in both adults and children, 
affecting 300 million people worldwide; with 5.4 million in the United Kingdom. Out of 
those affected, 4.3 million are adults and 1.1 million are children (Kudo et al., 2013; UK, 
2015). The mechanisms of asthma are triggered via an external stimulus, such as foreign 
bodies within inspired air, dry environmental conditions and exercise, stimulating T 
helper type 2 release cells (TH2) (Kudo et al., 2013). The release of TH2 causes an 
immediate responsiveness, mediated via immunoglobulin E (IgE), which gets captured 
via eosinophils and mast cells within the airway, causing the release of inflammatory 
molecules and subsequently, airway obstruction (Barrios et al., 2006). 
 
The term exercise-induced asthma (EIA) describes the transient narrowing of the airways 
seen after the stimulus of exercise in those with clinically diagnosed asthma, causing 
abnormal coughing, wheezing, chest tightness and/or dyspnoea (ATS., 1999; Dryden et 
al., 2010). Symptoms of EIA can also occur after exercise in individuals without a clinical 
diagnosis of asthma, and in these circumstances the term exercise-induced 
bronchoconstriction (EIB) is used (Holzer & Brukner, 2004; Dryden et al., 2010). The 
term EIB will be used within this study. 
 
The two hypothesised theories that cause these responses are the osmotic and the 
thermal hypotheses (Anderson & Daviskas, 2000; Rundell & Jenkinson, 2002; Stoloff et 
al., 2011). The osmotic hypothesis considers that during exercise, inspired air gets 
conditioned within the upper airway. This conditioning process evaporates airway 
surface liquid, causing dehydration as osmosis draws water from the nearby epithelial 
cells, in turn, shifting the condition process into the smaller, lower airways, causing 
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airway constriction (Anderson & Daviskas, 2000; Anderson & Kippelen, 2012). The 
thermal hypothesis states that airway cooling during exercise followed by rapid 
rewarming post causes oedema within the airway walls, assisting to the constrictive 
response (Anderson & Daviskas, 2000). 
 
Up to 80% of people with clinical asthma experience symptoms after exercise (Anderson 
& Holzer, 2000). It is also frequently reported within the elite athlete population; with 25% 
of European athletes at the Beijing Olympic Games, and 50% of winter sport athletes 
experiencing symptoms of EIB (Moreira et al., 2011). The high prevalence in elite 
athletes in sporting events such as swimming, winter and endurance sports reflect the 
mechanisms which onset EIB due to the high rates of ventilation during these events, as 
well as the environmental conditions these events are competed in. 
 
The athletic population, specifically those of an elite standard are more prevalent to 
asthmatic symptoms of EIB, however, the developed mechanisms theories do not fully 
explain the increase in susceptibility (Anderson & Holzer, 2000; Moreira et al., 2011). 
During training and competition, athletes are exposed to varied environmental 
conditions, airborne allergens and irritants which enhance the magnitude of the 
bronchoconstriction, coinciding to the increased prevalence in elite swimmers, winter 
sports and endurance athletes (Wilber et al., 2000; Knopfli et al., 2007). Most athletes 
present a performance driving mentality and increased pain threshold which affect their 
perception of airway constriction and its subsequent performance limitations, which 
although desirable within sports, may hinder athletes’ perception, education and 
treatment of EIB (Rundell et al., 2001). 
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To control the severity of the bronchoconstriction, athletes commonly use inhaled short 
action and long action β2-agonist before exercise to reduce respiratory symptoms 
(Dryden et al., 2010). The current World Anti-Doping Agency (WADA) guidelines for β2-
agonist allow for salbutamol, salmeterol and formoterol to be used following pre-
prescribed dosage, and to be monitored to ensure dosages and within therapeutic 
ranges, so a therapeutic usage exemption form (TUE) is not needed (WADA, 2015). 
 
Two physiological bronchial provocation tests used for the diagnosis of EIB are; the 
exercise challenge test (ECT), and the eucapnic voluntary hyperpnoea (EVH) (ATS., 
1999; Anderson et al., 2001; Dickinson et al., 2006). The ECT, recommended by the 
American Thoracic Society (ATS) aims to stimulate the airways via increased   ventilation 
during high intensity exercise at 80% to 90% heart rate max (HRmax), whereas the EVH, 
designed as a surrogate for the ECT by the American military, substitute exercise with 
controlled hyperventilation of a dry gas mixture at 80% maximum voluntary ventilation 
(MVV) (Anderson et al., 2001). For both challenges, a positive diagnosis occurs when 
forced expiratory ventilation (FEV1) falls by ≥10% when compared to the baseline lung 
function (ATS., 1999). 
 
Both provocation tests have been used for the diagnosis of EIB in athletes and are both 
accepted methods by the International Olympic Committee Medical Commission (IOC-
MC). Out of the two provocation tests, previous research has suggested that the EVH is 
a more sensitive method of diagnosis (Dickinson et al., 2006), although the methods 
used within the research have not followed current guidelines. A review by Stickland et 
al. (2010) found that previous research failed to complete the ECT following the current 
ATS guidelines, with lack of control of air water content, exercise intensity and duration, 
and follow up spirometry. These deviations would alter the severity of the ECT, leading 
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to an under or over diagnosis. In this case, the sensitivity of the EVH relative to the ECT 
is unclear. 
 
The review by Stickland et al. (2010) brings into question both the need to standardise 
the testing procedure, specifically the ECT, but also brings into question the previous 
research comparing the ECTs and EVHs sensitivity. Also, with the high prevalence of 
EIB in the athletic population, it is important to tests those who compete on a regular 
basis to ensure those who may be unaware are educated and informed, specifically in 
high risk sports. Therefore, the aim of the present study was to determine whether there 
was a significant difference between the ECT and EVH provocation tests for screening 
athletes when adhering to current guidelines.  
 
 
 
 
 
 
 
 
Chapter Two – Literature Review  MSc by Research 
6 
 
 
 
 
 
 
 
 
 
CHAPTER TWO 
 
LITERATURE REVIEW 
 
 
 
 
 
 
 
 
 
 
Chapter Two – Literature Review  MSc by Research 
7 
 
 
2.1 Asthma Pathology  
Asthma effects more than 300 million people all over the world, with approximately 
250,000 annual deaths caused by the disease (Kudo et al., 2013). Within the United 
Kingdom alone, 5.4 million people are affected by asthma (UK, 2015). 
 
The precise basis of the development of airway inflammation in patients with asthma is 
not fully defined (Barrios et al., 2006). Allergic asthma is a disease characterised by 
intermittent airway obstruction that causes difficulty in breathing, ultimately mediated by 
hyper-responsive bronchial smooth muscle, separated airway glycoproteins and 
inflammatory debris produced by airway goblet cells (Barrios et al., 2006; Kudo et al., 
2013). Two principal immune mechanisms lead to airway obstruction in allergic 
inflammation, both dependent on the presence of a terminally differentiated subset of T 
helper cells, the TH2 cell in the lung (Barrios et al., 2006). The TH2 cell secretes a highly 
characteristic cytokine repertoire that includes interleukin-4 (IL-4), IL-5, IL-9, and IL-13, 
all of which contribute to the manifestation of inflammation (Yazdanbakhsh et al., 2002; 
Kudo et al., 2013). Common inhaled allergens which stimulate TH2 cell are house dust 
mites, animal dander, fungi and pollen (Kudo et al., 2013). 
 
The immediate hypersensitivity response is mediated by IgE, an antibody isotype 
produced by B cells activated by IL-4 (Barrios et al., 2006). Circulating IgE is captured 
by immunoglobulin receptors (FCєRI) present on immune effector cells such as mast 
cells, basophils and eosinophils (Barrios et al., 2006). Subsequent encounters with 
antigen induce FCєRI cross linking, cellular activation, degranulation of mast cells, 
basophils and eosinophils, and the release of a variety of toxic inflammatory molecules, 
specifically leukotrienes, lipid mediators of inflammation derived from arachidonic acid. 
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Leukotrienes are short-lived molecules existing in a variety of isoforms which act through 
G protein-coupled receptors. They induce airway hyper-responsiveness, eosinophilia 
and airway glycoprotein hyper secretion, ultimately eliciting obstruction (Barrios et al., 
2006). 
 
The type 4 hypersensitivity response is mediated through TH2 cytokines IL-4 and 
predominantly IL-13, as it acts directly on airway smooth muscle and the epithelium to 
elicit airway hyper-reactivity, enhanced glycoprotein production, and eosinophilia. IL-4 
and IL-13 are signalled through the α chain of the IL-4 receptors, members of the Janus 
family of tyrosine kinases. Both contribute indirectly by aiding immediate hypersensitivity 
reactions. IL-4 and IL-9 are required for mast cell maturation, IgE recreation, and signals 
through α chain of the IL-4 receptors mediate eosinophil recruitment. More recent 
developments within the pathophysiology has found that the TH17 and TH9 cells also 
modulate asthma through the production of IL-17A, which enhances smooth muscle 
contractibility, and IL-17F and IL-22, which induce airway inflammation (Kudo et al., 
2013). 
 
Most pathologic patterns of asthma have been derived from autopsy studies. These 
patterns are based on individuals who died of asthmaticus over-inflation and mucus 
plugs obstructing the medium-sized bronchi, small bronchi and bronchioles. In 
asthmatics, over-inflation occurs when the lungs fill the chest cavity during status 
asthmaticus and do not collapse when the pleural space is opened, even when the lungs 
appear normal between attacks. Mucous plugs are made of heavily viscous inspired 
mucus produced by both sub-mucosal gland hypertrophy and goblet cell hyperplasia 
which fill both bronchi and bronchioles (Kudo et al., 2013). In asthmatics, mucin and 
goblet cells in the epithelium can be three times higher when compared to a non-
asthmatic. Patients dying of status asthmaticus have a two to three fold increase in the 
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amount of airway smooth muscle, especially in the medium sized bronchi, with thickness 
increased with age, due to myofibroblast, characterised as airway remodelling. Airway 
remodelling has a profound effect on airway narrowing mechanics, exacerbating the 
chronicity and progression of the disease (Kudo et al., 2013). It is postulated that the 
injured airway epithelium acts as a continuous stimulus for airway remodelling.  
 
2.2 Exercise Induced Bronchoconstriction Mechanisms 
EIB is described as the drying and cooling of the intra-thoracic airways and mucosa, 
stimulating the release of inflammatory mediators causing airway narrowing during or 
following exercise (Rundell et al., 2002; Tecklenburg et al., 2007; Anderson, 2012; 
Mainardi et al., 2012). The fundamental mechanics of EIB are believed to be part of a 
multifaceted approach, explaining why both healthy and asthmatic individuals can 
develop EIB (Rundell et al., 2002; Parsons & Mastronarde, 2005; Stoloff et al., 2011). 
The mechanism whereby airway narrowing occurs due to the response of exercise is 
subdivided into two key hypotheses; the thermal and the osmotic (Anderson & Daviskas, 
2000; Rundell et al., 2002; Stensrud et al., 2006).  
 
The thermal hypothesis considers that EIB is initiated by the thermal effects on the 
airways during and post exercise, that is, airways cooling during exercise following rapid 
rewarming of the airways after exercise. These thermal effects are proposed to cause a 
reactive hyperaemia of the bronchial microvascular, and oedema of the airway wall 
(McFadden et al., 1986; Anderson & Daviskas, 2000). Stimulation during post exercise 
environmental conditions may affect severity of EIB through reducing the reactive 
hyperaemia. McFadden et al. (1986) aimed to observe changes in respiratory airways 
whilst controlling the temperature and humidity during both exercise and recovery. Data 
confirmed that when the respiratory tract is rapidly rewarmed post exercise, there is a 
significant decrease in FEV1 compared to a controlled temperature and gradual 
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rewarming, even when exercise was performed in sub-freezing temperatures, 
concluding that thermal aspects do play a part in constriction. 
 
The osmotic hypothesis puts forward that the increase in ventilation during exercise and 
subsequent conditioning of the inspired dry air causes dehydration within the respiratory 
cells, initiating the contraction of the bronchial smooth muscle (Anderson & Daviskas, 
2000), and because EIB can occur without significant cooling of the airways, the osmotic 
effects are thought to be more important than the thermal effects (Rundell et al., 2002). 
During activities with high ventilatory flow rates in dry conditions, the conditioning of 
inspired air becomes more intensive, requiring the smaller airways to aid in the 
conditioning process. It is theorised that water loss from the airways surface causes 
water to move out of nearby cells in response to increases in osmolality (Anderson & 
Daviskas, 1997; Rundell et al., 2002).  
 
2.2.1 Airway Inflammation 
Airway inflammation during EIB plays a pivotal role in airway sensitivity during the 
osmotic stimulus (Dryden et al., 2010). Inflammation response occurs via stimulation of 
the mast cells and eosinophils within the respiratory tract due to increased ventilation 
during exercise (Hallstrand et al., 2007; Anderson, 2012). Mast cells are highly 
developed cells derived from bone marrow, associated with structures such as blood 
vessels and nerves, in proximity to surfaces that interface the external environment 
(Metcalfe et al., 1997; Anderson, 2012). When activated, mast cells and eosinophils 
release mediators, including histamines, leukotrienes and eicosanoids, such as 
cysteinyl, leukotraines and prostaglandin D2, inducing allergic inflammation (Metcalfe et 
al., 1997; Hallstrand et al., 2007; Philip et al., 2007; Mainardi et al., 2012).  
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Two principle immune mechanisms are believed to lead to airway obstruction, both 
dependent on T helper cells (Marsh et al., 1994; Barrios et al., 2006). Immediate 
responsiveness is mediated by IgE. IgE antibody is associated with atopic allergies and 
linked with T Cell-B interaction. Stimulation between the T helper cells and B-cells, and 
the release of IL-4 and IL-13 result in a specific IgE response (Marsh et al., 1994). These 
IgE responses are bound to high affinity IgE receptors on mast cells and basophils 
(Walley & Cookson, 1996). The input IL-4 enhances the degranulation of mast cells by 
increasing the saturation of IgE receptors with allergen complexes (Walley & Cookson, 
1996). IL-13 is a TH2 cytokine which binds to the α chain of IL-4 (Wills-Karp et al., 1998), 
playing a key role in airway hyper-responsiveness. Research by Wills-Karp et al. (1998) 
found a blockade of IL-13 via soluble IL-13α2-IgEFc fusion protein 24 hr before intra-
tracheal allergen challenge resulted in significant decrease in airway hyper-
responsiveness, concluding that IL-13 is the primary T cell derived factor responsible for 
allergen-induced airway inflammation and EIB. 
 
2.2.2 Refractoriness 
Refractoriness is the time post exercise, whereby if an asthmatic develops EIB and then 
spontaneously recovers within about an hour, a secondary exercise stimulus results in a 
marked reduction in EIB in about 50% of subjects (Larsson et al., 2011). Research by 
Larsson et al. (2011) found that completing one ECT  achieved a fall in FEV1 of 26.9%, 
which reduced to a 13.3% after a second challenge. Because refractoriness disappears 
if an asthmatic is treated with a nonsteroidal anti-inflammatory medication, it may be 
mediated by a prostaglandin, such as prostaglandin E2 (PGE2). PGE2 is a known 
bronchodilator produced in the lungs (Suman et al., 2000). Suman et al. (2000) study on 
PGE2 effects on guinea pigs found that prolonged hyperventilation caused a slow 
release of PGE2, due to airway cooling, drying or stretching, but could not fully conclude 
that PGE2 involvement caused refractoriness. 
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2.3 Affected Populations 
EIB has become more common place in athletes competing at an Olympic level, with 
607 athletes at the Sydney Olympics notifying the medical commission of  the use of a 
β2-agonist, a notable increase above the 383 athletes seen at the 1996 Atlanta games 
(Holzer et al., 2002). However, a recent study at the Beijing Olympics reported that one 
in four European athletes experienced symptoms associated with EIB (Carlsen et al., 
2008). Overall, high performing athletes are at a higher risk of EIB compared to the 
general population (Knopfli et al., 2007). Although EIB can affect any athlete, with up to 
50% of athletes suffering from EIB (Wilber et al., 2000; Holzer et al., 2002; Parsons & 
Mastronarde, 2005), it is more prevalent in certain sports, specifically: endurance sports, 
swimming and winter sports, or sports that induce a high ventilatory component (Rundell 
et al., 2002; Moreira et al., 2011). 
 
2.3.1 Winter Sports 
Larsson et al. (1993) investigated elite cross country skiers found that due to the cold 
and dry environmental conditions experienced during both training and competition, 
asthmatic symptoms occurred in 55% of elite skiers. Similar research by Rundell et al. 
(2001) found that in a wide range of elite cold-weather athletes, EIB was present with 
26% of subjects being classified with the condition. 
 
Wilber et al. (2000) conducted a case study on the US winter Olympic team and aimed 
to determine whether differences occurred within winter sports, even those performed in 
similar environmental conditions, could affect possible EIB rates. 23% of the 170 subjects 
from 7 sports had incidences of EIB post testing. Although environmental conditions were 
similar, certain sports had greater incidences of EIB. 50% of cross country skiers were 
diagnosed with EIB, coinciding with previous research by Larsson et al. (1993). 6 out of 
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7 sports did show incidences of EIB, with biathlon being the exception. Wilber et al. 
(2000) concluded that due to an unseasonably warm day during competition (+11°C), 
the stimulus of cold weather was reduced. The similarity between biathlon and cross-
country skiing should procure a different result when performed in a cold, dry condition. 
Dickinson et al. (2006) also researched the prevalence within winter sports, specifically 
British short track speed skaters and biathletes using the ECT, EVH and sports specific 
tests (SST). Out of the 14 athletes tested, 10 achieved peak falls in FEV1 ≥10% of 
baseline, but results were dependent on the screening method used. The EVH had the 
highest percentage of falls ≥10%, with 10 out of the 14. For the ECT, none of the 
participants had falls ≥10%, and the SST had 3. 
 
2.3.2 Summer and All Year Round Sports 
Weiler et al. (1998) worked alongside the US summer Olympic team addressing EIB 
incidences in multiple sports for athletes who competed in the 1996 Atlanta Olympics. 
Out of the 699 athletes who took part in the study, 17% were diagnosed with having EIB. 
With high ventilatory rates seen in track, road and off road cycling, these sports had the 
greatest asthmatic response with 50% of athletes being diagnosed.  
 
Research by Schoene et al. (1997) on US elite track and field athletes found that after 
their events, long distance athletes, such as 10km runners and 20km walkers had 
diagnosed cases of EIB, due to their larger vital capacities and high ventilation rates 
during events. Similarly, Helenius et al. (1997) research with 213 elite track and field 
athletes, found that event type relates to the amount of athletes who get diagnoses with 
asthma. In their results, like Schoene et al. (1997), long distance runners were much 
more susceptible to EIB symptoms compared to sprinters, field eventers and sedentary 
individuals, due to short events do not stimulate the ventilation system for a sufficient 
amount of time to cause the thermal or osmotic changes. 
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Studies in all year round sports like football have found varying results into the severity 
of EIB above the general population. Ventura et al. (2009) investigated young football 
players who play as part of a major team via self-reported questionnaire. These athletes 
had a slightly greater percentage of EIB than that seen in recreational players, but not 
enough to be statistically significant (5.1% = Players, 2.9% = Recreational). Although the 
study found no difference, the design was aimed more to allergies with airborne particles 
rather than a pre-existing asthmatic condition. Research by Rupp et al. (1992) analysed 
a range of middle and high school athletes with possible unrecognised EIB found that 
out of the 230 tested, 66 were diagnosed with EIB. Although participants were not 
selected on an asthmatic basis, those with a medical history criteria, or risk factors 
indicating EIB, such as abnormal spirometry results were chosen. 
 
2.3.3 Athletes at High Risk 
There is an overwhelming body of evidence which shows that athletes, specifically those 
of a high standard are at an increased risk of asthmatic symptoms and EIB (Larsson et 
al., 1993; Wilber et al., 2000; Knopfli et al., 2007; Moreira et al., 2011). However, the 
reasoning and mechanisms for this remain unclear, with possible theories relating to; 
increased exposure to environmental factors, genetic pre-disposition and 
physiological/psychological variations (Moreira et al., 2011).  An elite athlete goes above 
and beyond, both physiologically and psychologically, when training and competing, 
which can affect the diagnosis of asthma and EIB (Rundell et al., 2002). Psychologically, 
elite athletes become more performance driven, and look upon asthma interventions as 
both a physical and psychological battle against their training and competing (Rundell et 
al., 2002). During training and competition, athletes may become more exposed to 
triggers which influence the occurrence of EIB, such as airborne allergens and irritants 
for example, pollen and exhaust fumes, as well as environmental conditions with extreme 
temperatures and differing humidities (Rundell et al., 2002). Intensive training can 
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increase susceptibility via effecting autonomic regulation and cardiac function, thus 
effecting airway smooth muscle (Parsons & Mastronarde, 2005; Moreira et al., 2011). 
 
2.4 Gender Variations 
Although athletes have a high prevalence of EIB when compared to the general 
population, little is known about the differences between the genders (Langdeau et al., 
2009). Prior to puberty, asthma is greater in males, with females being greater post 
puberty. The possible shift may be due to the start of the menstrual cycle, caused by the 
release of progesterone and oestrogen (Balzano et al., 2001; Postma, 2007). In 
conjunction with Balzano et al. (2001) research by Stanford et al. (2006) with females 
who recreationally train found a significant differences in forced vital capacity (FVC) and 
FEV1 when comparing the early follicular (day 5) and mid-luteal (day 21) parts of the 
menstrual cycle.  
 
In the athletic population, research by Langdeau et al. (2009) into gender variations for 
respiratory symptoms and asthma found that for exercise-induced respiratory symptoms, 
female athletes were significantly more susceptible when compared to males. The 
difference was possibly down to hormonal variations, following previous literature 
(Balzano et al., 2001; Postma, 2007), although no data was collected within the area  
and so this is merely speculation (Langdeau et al., 2009). 
 
2.5 Prevention and Medication 
There are multiple options to prevent EIB, all relating to modifying either the stimulus, or 
the mechanism of EIB (Anderson, 2012). To reduce water loss during exercise, 
conditioning the inspired air to body temperature (37°C) and 100% relative humidity (RH) 
prevents EIB in the majority of cases (Anderson, 2012). Stensrud et al. (2006) 
researched the effect of respiratory function at different humidity levels on EIB sufferers. 
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When exercise was completed at 95% humidity, significant increases were found in both 
respiratory functions, such as oxygen uptake (V̇O2), with significant reductions in FEV1 
post exercise when compared to exercise completed at 40% humidity. 
 
As EIB is stimulated via the release of mediators, suppression of their secretion via 
pharmacological agents, such as β2-agonist, which when used prior to exercise, 
effectively prevents asthmatics suffering from EIB (Anderson, 2012). A case study by 
Stoloff et al. (2011) on a 45 year old male who had shown symptoms related to EIB, 
reduced and removed those symptoms after a prescription of a β2-agonist post lung 
function assessment. The supplementation of fish oils has also been evaluated as a 
method of reducing EIB symptoms during exercise. Mickleborough et al. (2006) research 
found that after 3 weeks of supplementation, lung function reduced below diagnosable 
levels against both a control and a placebo group, creating a 31% reduction in 
bronchodilator usage. With elite athletes, Mickleborough et al. (2003) found similar 
results to the general population, with all 10 participants experiencing significant 
reductions in EIB intensity. Supplementation of fish oil has anti-inflammatory potential 
through eicosapentaenoic acid and arachidonic acid suppressing inflammatory 
mediators (Mickleborough et al., 2003; Mickleborough et al., 2006). 
 
Preventative measures via controlled exercise programs are regularly prescribed to 
asthmatic patients as a way to improve aerobic capacity (Matsumoto et al., 1999). 
Research by Matsumoto et al. (1999) found that completing 30 minutes of high intensity 
swimming at 125% lactate threshold, six times per week for six weeks, subjects with pre-
diagnosed asthma and EIB significantly decreased their fall in FEV1 to levels below EIB 
diagnosis range. The reduction was due to the increase in aerobic capacity, rather than 
an increase in histamine responsiveness, with EIB results being reduced on a 
multifunction format, both on a swimming and cycle ergometer (Matsumoto et al., 1999). 
 
Chapter Two – Literature Review  MSc by Research 
17 
 
 
2.5.1 World Anti-Doping Agency Guidelines 
For athletes who compete and suffer from asthma or EIB, the WADA have guidelines to 
follow to allow for the use of β2-agonists (WADA, 2015). Previously, all β2-agnoists 
required proof of airway hyper-responsiveness when submitting therapeutic use 
exemptions forms, but recent changes have allowed for the exemption of inhaled 
salbutamol, formoterol and salmeterol, depending on dosage. For salbutamol, a 
maximum of 1600 micrograms (µg) are allowed over 24 hours. For formoterol, a 
maximum delivery dose of 54 µg is allowed over 24 hours. Salmeterol can be used in 
accordance with therapeutic regimen (WADA, 2015). 
 
For those who require an assessment of their asthmatic status, a test for the reversibility 
of bronchospasm can be performed, whereby an increase of ≥12% in FEV1 after an 
inhaled β2-agonists demonstrates the need for asthma medication. For evaluation of EIB, 
the ECT and EVH tests are recommended with a ≥10% fall in FEV1 meeting the criteria 
for the use of β2-agonists (WADA, 2015). For those athletes who just require exempt β2-
agonists, the need for EIB evaluation is not necessary, but encouraged to evaluate 
current medication status (ATS., 1999).  
 
2.6 American Thoracic Society Guidelines for the Diagnosis of EIB 
The ATS model is broken down into two predominant areas; an ECT and spirometry 
assessment. The ECT aims to subject the participant to exercise which induces 
significant ventilation (V̇E), measured through a percentage of predicted heart rate max 
(%HRmax). An 80-90% HRmax (220 - age in years) provides vigorous exercise conditions 
whilst eliciting a V̇E rate of 40-60% predicted max (Anderson et al., 2010). ATS. (1999) 
concur that physical variances such as anaerobic/aerobic fitness and body weight may 
hinder a participant’s ability to obtain a %HRmax or percentage of predicted max 
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ventilation (%V̇Emax), but also state the HR protocol is generally effective and practical. 
However, Trumper et al. (2009) suggested that these physical variations, specifically 
based in HR, means applying a prediction based formula creates an increased risk of 
misjudging the optimum exercise intensity. Rundell et al. (2002) also suggests that due 
to the increased level of conditioning attained by athletes, there is the potential to under 
stimulate the ventilatory system through an underestimation of the exercise intensity. 
Similarly, these theories should be both addressed to the range of physical conditions, 
with people below their predicted HRmax being over stimulated during an ECT, becoming 
unable to maintain that 80-90% HRmax. Although assessment via ECT based on %HRmax 
is an efficient and well documented method, the physical variance can be a factor when 
it comes to an accurate diagnosis. As EIB occurs within the ventilatory tract, focusing the 
intensity of exercise upon a subject’s %V̇Emax would remove ambiguity caused by fitness 
levels and physical conditioning. 
 
2.6.1 Evaluation of the Heart Rate Protocol 
As previously stated, ATS guidelines suggest that a ventilatory protocol can be 
completed rather than a HR protocol (ATS., 1999), but it remains unclear whether it is a 
potentially superseding method. Research by Trumper et al. (2009)  aimed to equivocally 
address the proposed statement that a HR based protocol does not ensure sufficient 
intensity for inducing EIB. The pretence of the study focused on the aerobic to anaerobic 
pathway shift, with evaluation of lactate concentrations [La+] and variance between 
subjects was the key measure within the study. Depending on [La+], subjects FEV1 
scores were divided into groups who experienced anaerobic conditions, with [La+] 
>6mmol/L, against those who stayed within the aerobic pathways with [La+] <6mmol/L. 
The results found that out of the 100 subjects, 56 did not reach the anaerobic pathway, 
remaining below the required conditions. When both groups got compared with FEV1 
data, those who had achieved a >6mmol/L [La+] had significantly reduced lung function 
compared with those who remained aerobic.  
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Although the research by Trumper et al. (2009) would claim that a HR based method is 
insufficient to induce EIB, some stipulations must be made about the research model 
undertaken, before a true judgement can be formed. Firstly, subject selection, whereby 
100 clinically healthy individuals were selected, but literature into EIB is clear that the 
prevalence of the condition is much greater in those who have a pre-diagnosed asthmatic 
condition (Lacroix, 1999; Stoloff et al., 2011; Mainardi et al., 2012). The symptoms of EIB 
have been recorded in those who do not have asthma (Anderson, 2011), but a review of 
method should seemingly be performed upon those at highest risk. Secondly, data 
comparison; although the data collected could be enough to conclude that a HR based 
method lacks intensity in certain populations, choices of physiological markers remained 
vague, such as the choice of a >6mmol/L [La+]. Finally, spirometry assessments were 
completed only once, 10 minutes post exercise. The peak fall in FEV1 has been recorded 
between 6 – 12 min post exercise (Rundell et al., 2002), suggesting that the individual 
time choice would be significant, but the question of physical variances between subjects 
should seemingly require multiple assessments like the original method (ATS., 1999). 
 
The study by Trumper et al. (2009) concluded that a HR protocol was seemingly 
insufficient when testing a wide range of individuals, but the method deviated from the 
current standard. To suggest that a method is flawed would require a comparative 
method design which aims to remove those physiological variances and create and 
individualist testing protocol, such as analysis of HRmax prior, rather than a predicted 
percentage, or as EIB is a ventilatory condition, focus exercise intensity upon a 
percentage of V̇Emax. As stated, an EIB ECT diagnosis should look more towards a 
ventilatory method rather than a %HRmax, as EIB has the causal link with the respiratory 
system (Storms, 2003; Trumper et al., 2009; van Leeuwen et al., 2012), although current 
methods use %HRmax to elicit a sufficient V̇E (ATS., 1999). Research onto the validity of 
the respiratory method by Anderson et al. (2010) found that the current ATS method is 
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of sufficient intensity to induce V̇E rates required to induce hyperventilation, in both adults 
and children (Adults: 56.8% & 58.0% V̇Emax, Children: 54.7% & 56.3% V̇Emax).; However, 
EIB positive diagnoses were only seen in 161 out of 373 of asthmatic subjects, 
suggesting subjects remained under stimulated when compared to other methods of 
testing (Cabral et al., 1999; Holzer et al., 2002; Stensrud et al., 2006)  
 
Trumper et al. (2009) focused predominantly upon the level of physical exertion during 
the test, stating that subjects must achieve a state of anaerobic exercise. A current 
ventilator marker that can be used to assess anaerobic threshold is the gas exchange 
threshold (GxT). The GxT method for assessing anaerobic threshold is a non-invasive 
procedure whereby a breakpoint is seen within the breath by breath values of carbon 
dioxide elimination (V̇CO2) against oxygen consumption (V̇O2), caused by the increase 
in V̇CO2 from bicarbonate buffering of lactic acid (Magalang & Grant, 1995; McArdle et 
al., 2009). Research by Haverkamp et al. (2005) onto the GxT within asthmatics and 
diagnosis of EIB found that, when subjects performed an ECT at 90% maximum oxygen 
consumption (V̇O2max), rather than 80-90% HRmax, post ECT FEV1 was significantly 
reduced in both subjects who are EIB positive and negative, although the gas exchange 
disturbance took sizably longer in EIB negative subjects (3 min positive; 35 min 
negative). The GxT method for assessing anaerobic threshold, and subsequently EIB 
would seem a more refined marker of ventilation than 80-90% HRmax, although 
determination of exercise intensity which induces GxT is required before undertaking 
and EIB assessment. 
 
The benefits for a ventilation based protocol would be the removal of any individual 
physiological variations which may occur due to physical background (Trumper et al., 
2009), although it would require an initial assessment to define a ventilation level 
required to elicit a sufficient intensity. Research into the ATS relationship with V̇E has 
found that the use of %HRmax is sufficient enough to induce an V̇E that caused EIB 
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(Anderson et al., 2010), it remains questionable whether a more specific ventilatory point 
would be more exacting, such as the GxT, to induce the respiratory and vascular 
conditions sufficient enough to cause EIB. The stipulation would be whether an initial 
assessment would be beneficial, when current methods requiring one session with 
minimal equipment still find positive results. 
 
2.7 Exercise Challenge Test 
The ECT uses exercise to stimulate a high minute ventilation through the mouth to 
increase the airway dehydration stimulus of conditioning inspired air, which can 
performed both in a laboratory or field environment (Holzer & Brukner, 2004; Anderson, 
2011). Field tests benefit from the availability to perform a range of vigorous, sports 
specific exercises, with the increase in portable spirometry devices making complete 
assessments much easier, although the large range of equipment needed, and the limit 
control of air quality may effect results (Anderson, 2011). Laboratory tests, although 
restrictive of sports specific testing, normally completed on treadmill or cycle ergometer, 
have the benefit of control of inspired air conditions, as well as online gas meters (Holzer 
& Brukner, 2004; Anderson, 2011). Limitations and false negative results occur due to 
the exercise intensity and method undertaken. ATS state that exercise intensity should 
ramp up rapidly over the first 2 min and be adjusted afterwards to maintain HR at the 
target level (ATS., 1999). An intensity level too low can lead to the release of 
bronchodilation constrictors, such as PGE2 which serve to protect the airways 
(Anderson, 2011). 
 
ATS guidelines for the ECT (ATS., 1999) are currently regarded as the standardised 
method for testing using exercise as a stimulus. The method design aims to stimulate 
the airways by exercising at 80-90% HRmax, or at a 40-60% V̇E of predicted MVV for ≥4 
min in a dry air environment (ATS., 1999). Control of inspired air is vital as low water 
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content is needed to stimulate the conditioning process (Rundell et al., 2002; Anderson, 
2011). ATS. (1999) state that participants should inspire air of 20-25˚C and <50% relative 
humidity. Optimally, water content of the inspired air should be <10mg/L. At air 
temperatures of ≤10˚C, inspired air is sufficiently dry, specifically when testing those who 
complete exercise in cold environments (ATS., 1999; Rundell et al., 2002; Anderson, 
2011).  
 
Exercise duration is also a key factor to the diagnosis of EIB, as time needed to achieve 
target HR or V̇E may vary for age, physical fitness and body weight (ATS., 1999; 
Anderson, 2011). For children, target HR or V̇E may be achieved quicker than adults, 
affecting exercise time. For children, an exercise duration of 6-7 min may be needed to 
elicit EIB, where adolescents or adults may need up to 8 min (ATS., 1999; Rundell et al., 
2002; Holzer & Brukner, 2004; Anderson, 2011). Once target HR is achieved, it should 
be maintained for ≥4 min, but it is important to reach this point rapidly over the first 2-3 
min (ATS., 1999; Anderson, 2011). Although two ergometer methods have been 
developed, the treadmill method is preferred over the cycle ergometer, due to the more 
rapid increase in V̇E in response to running, and the higher peak oxygen uptake achieve 
compared to the cycle method (ATS., 1999). 
 
FEV1 is the current most reliable marker for the assessment of EIB, with a fall of ≥10% 
from baseline being regarded as a positive diagnosis, although ≥15% has been used, 
specifically for field based testing (ATS., 1999; Anderson & Holzer, 2000; Holzer & 
Brukner, 2004). Rundell et al. (2000) has also stated that a fall in FEV1 of ≥7% indicated 
an abnormal airway response in the elite athlete population, as to try and reduce the 
number of false positives. Assessment of FEV1 should be performed following the ATS 
and European Respiratory Society (ERS) method for spirometry testing (Miller et al., 
2005). An appropriate spirometry testing procedure consists of pre ECT, 5, 10, 15, 20 
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and 30 min post, although earlier testing at 1 and 3 min may be completed as EIB may 
appear at the cessation of exercise. On average, the lowest FEV1 values are achieved 
between 5-12 min after the completion of the ECT (ATS., 1999; Anderson, 2011). When 
testing, a minimum of 2, preferably 3 assessments should be obtained, with highest and 
second highest FEV1 values not differing by 0.15L (Miller et al., 2005). After 30-60 min, 
FEV1 spontaneously recovers to 95% of the baseline value, although if participants do 
not recover to less than 10% of baseline value, a bronchodilator may be administered if 
the participant has a previous asthmatic condition. 
 
Although the laboratory ECT has some benefits, such as control of environmental 
conditions and testing protocols, the field test or sports specific has been used by 
previous research (Rundell et al., 2000; Wilber et al., 2000; Rundell et al., 2004). The 
variability in environmental conditions and exercise intensity and duration with field 
testing makes test-retest difficult to control (Rundell et al., 2004). Similarly, although 
laboratory tests have a more controlled environment, the environments in air conditioned 
laboratories may not be sufficiently provocative, as air water content may not be 
sufficiently low to induce EIB (Dickinson et al., 2006). The use of environmental 
chambers may impact in the control of air temperature, RH and water content. Limited 
research has been completed in regards to completing an ECT within a controlled 
environment. Stensrud et al. (2007) used an environmental chamber to evaluate the 
effect of performing an ECT in room temperature and subfreezing temperatures, 
20.2°C±1.1 and -18°C±1.4 respectively, on EIB diagnosis. Using an adjusted ECT 
protocol, where a 4 min phase was used to reach target HR of above 95% HRmax, with 4 
min at target HR, significant increases in FEV1 were found after exposure to cold weather 
compared to room temperature. During cold weather assessment, peak oxygen 
consumption (V̇O2peak) was reduced in the last 4 min, correlating with participants 
response that respiration was more difficult compared with regular conditions, possibly 
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due to starting high intensity exercise in a cold environment without a warm-up, or the 
reduced running speed (Stensrud et al., 2007). 
 
2.8 Eucapnic Voluntary Hyperpnoea 
Indirect challenges to assess bronchial hyper-responsiveness are becoming increasingly 
used for both research and assessment (Anderson, 2011).The bronchial provocation 
tests most used to identify EIB include; ECT (Laboratory based or Field), EVH and 
pharmacological agents such as hypertonic saline and mannitol inhalation (Anderson & 
Holzer, 2000; Rundell et al., 2004; Anderson, 2011). 
 
The EVH assessment was developed, standardised and validated by the US Army at the 
Walter Reed Medical Centre, as a surrogate to the ECT, in order to reduce the likelihood 
of false negatives and increase safety issue related with the ECT (Anderson et al., 2001; 
Anderson, 2011). The test design is a bronchial provocation test, aiming to stimulate the 
airways via the respiration of dry air, causing osmotic and thermal consequences due to 
humidifying the inspired air, without the requirement to complete exercise (Anderson et 
al., 2001; Rundell et al., 2002). The IOC-MC validated the EVH as the recommended 
method for analysis of the need for asthmatic medication, specifically in athletes, with 
the benefits over an ECT such as; lower cost, induced V̇E rates greater than exercise 
and increased safety (Argyros et al., 1995; Anderson et al., 2001; Holzer & Brukner, 
2004; Rundell et al., 2004; Anderson, 2011). The usefulness of the EVH method is in 
reducing the over or under diagnosis of EIB (Anderson, 2011). 
 
The current method for EVH involves respiring dry air at 30 times FEV1 (85% MVV) for 
6 min (Anderson et al., 2001; Sue-Chu et al., 2010; Anderson, 2011). Specific aspects 
should be followed when completing an EVH and ECT assessment. Prior, no 
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bronchodilators should be used 48hr before, although should not be withheld if needed. 
Caffeine should not be consumed via food or drink 24hrs prior, although may vary 
depending on laboratory. Vigorous exercise should not be undertaken 4hrs prior, 
preferably not on the day of testing (Anderson et al., 2001). The condition of the inspired 
air is vitally important for a valid assessment, with early studies performing in cold air 
environments (Anderson, 2011). Medical grade mixture gas cylinder containing 21% 
oxygen, 4.9-5.1% carbon dioxide with balanced nitrogen can be used (Anderson et al., 
2001; Holzer & Brukner, 2004; Rundell et al., 2004; Sue-Chu et al., 2010). The higher 
CO2 content is used to maintain eucapnia over the range of ventilation (Holzer & Brukner, 
2004; Anderson, 2011). 
 
Certain limitations are present. The need to maintain eucapnia throughout a wide range 
of ventilation rate means ventilation needs to be between 40-105 L·min-1. If ventilation is 
outside these limits, end tidal CO2 needs to be monitored, as hypocapnia  is a 
bronchoconstricting stimulus which can cause acidosis (Anderson, 2011). Secondly, the 
standard protocol of 30 times FEV1 (85% MVV) for 6 min is only appropriate for athletes 
or participants who perform regular exercise, as high ventilation rates can cause a severe 
reduction in FEV1 (Anderson, 2011). For asthmatics, adaptation to the method by the 
reduction of ventilation rate to 21 times FEV1 or duration of 4 min would induce an MVV 
of ~60% in asthmatics or untrained participants (Brummel et al., 2009). 
 
A positive diagnosis during an EVH assessment is a fall in FEV1 at ≥10% that of baseline 
(Holzer & Brukner, 2004). An appropriate spirometry procedure consists of pre EVH, 
post, 5, 10, and 20 min after testing, with the lowest value at each time point used to 
calculate percentage fall (Argyros et al., 1996). Other studies have used varying time 
points during post EVH testing, Sue-Chu et al. (2010), tested at 3, 5, 7, 10 and 20 min 
post EVH, with Rundell et al. (2004) testing at 5, 10, and 15 min. 
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2.9 Exercise Challenge Test vs. Eucapnic Voluntary Hyperpnoea 
With the large number of athletes previously diagnosed with EIB, with up to 50%, the 
most accurate and valid method for assessment should be evaluated (Rundell et al., 
2004). The current methods utilised in clinical research are the ECT, developed by the 
American thoracic society (ATS), and EVH, the current standard by the IOC-MC (Rundell 
et al., 2004). Research has been completed assessing the sensitivity of both methods, 
as well as variations of the ECT. 
 
Rundell et al. (2004) assessed the sensitivity between the EVH method and a sports 
specific field ECT (SSECT), aiming to evaluate whether EVH is sufficient enough when 
compared to an ECT. The ECT design consisted of 6-8 min of either ice skating, cross 
country skiing or running, in environmental conditions of 5.6˚C±2. The EVH protocol 
required participants to respire at 30 x FEV1 for 6 min, with a fall in ≥10% in FEV1 being 
regarded as a positive diagnosis for both assessments. From the 38 participants who 
completed the research, 11 and 17 positive diagnoses were made from the ECT and 
EVH respectively. Although numerically, more participants were diagnosed with EIB post 
EVH, the mean fall in FEV1 was greater post ECT (20.5±7.3% to 14.5±4.5%). V̇E during 
EVH was recorded at 104±26 L·min-1, with the measured V̇E being equivalent to 27.7 x 
FEV1. They concluded that the EVH has a greater chance of identifying EIB when 
compared to the ECT, specifically those who perform in cold weather sports. 
 
Similar research to Rundell et al. (2004), research by Dickinson et al. (2006) evaluated 
winter sports athletes (10 speed skaters, 4 biathletes) using EVH, laboratory ECT (LECT) 
and sports specific ECT (SSECT) methods for diagnosis EIB. LECT involved treadmill 
running for 8 min, at a >90% HRmax in environmental conditions of 18°C and 56% RH. 
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SSECT required speed skaters to skate for 6 min at 11 and 12 s per 250m, with biathletes 
required to complete a 20 min simulated race in 1-2°C at 31-34% RH. EVH followed 
standard protocol of 30 x FEV1 for 6 min, recommended by Anderson et al. (2001). Based 
on the ≥10% fall in FEV1 being regarded as positive, 10 of the 14 had a positive response 
to EVH, with 3 and 0 being diagnosed from the SSECT and LECT respectively, 
concluding that the EVH is the more sensitive challenge for the detection of EIB in 
athletes. Although EVH has been regarded as the more sensitive by Dickinson et al. 
(2006), stipulations should be made about the control of each study. EVH allows for 
greater control over the two main contributors; inspired air water content and V̇E 
(Dickinson et al., 2006). 
 
Research by Castricum et al. (2010) followed the structure that Rundell et al. (2004) and 
Dickinson et al. (2006) had previous used. Castricum et al. (2010) evaluated a group of 
33 elite swimmers using the EVH, field swim test and LECT. Similarly to both Rundell et 
al. (2004) and Dickinson et al. (2006), the EVH was the most sensitive test with 18 of the 
33 subjects experiencing a positive test compared to the one for the field swim and four 
for the LECT.  
 
Although colder environmental conditions have proven significantly effect at stimulating 
EIB mediators (Stensrud et al., 2007), it is not the sole factor in stimulating a positive 
response. Dickinson et al. (2006) reported that even when exercise was performed in 
temperatures sufficiently low enough for elicit EIB, 1°C and 8°C respectively, only 3 
diagnoses were found compared to EVH, performed in 19.1°C, which diagnosed 10. The 
water content of the inspired air may be a more important factor, rather than cold air 
alone (Evans et al., 2005).   
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The ability to control environmental conditions during an ECT, where the inspired air is 
considered sufficiently dry (<10°C) (Anderson, 2011), could correct for misdiagnosis 
when comparing LECT and EVH tests. No specific studies have been found where LECT 
has been performed in a controlled environment following the current ATS guidelines 
(ATS., 1999), and compared to an EVH assessment following IOC-MC and Anderson et 
al. (2001) guidelines measuring sensitivity, although Evans et al. (2005) evaluated cold 
temperature and room temperature air ECT and EVH respectively, using chilled air from 
a dry gas cylinder. At approximate temperatures of 22°C and -1°C, a significant 
difference was found when comparing room temperature EVH and cold temperature ECT 
(-15.22% vs -10.70%), where other comparisons were non-significant.  
 
2.10 Spirometry  
Spirometry is the physiological test which measures how individuals inhale or exhale 
volumes of air over a function of time, aimed at assessing respiratory health (Miller et al., 
2005). Miller et al. (2005) describes the current standardised method of spirometry, 
which consists of three distinct phases; 1) maximal inspiration, 2) a rapid exhalation and 
3) continuation of exhalation until test end. Prior to the initial phase, demonstration of the 
appropriate technique should be performed by the technician, with descriptive 
information about equipment and usage. During phase one, completion of maximum 
inspiration should be performed by the subject. During phase two, subjects should be 
encouraged to push or blast, rather than just blow when exhaling. A standard spirometry 
assessment should be performed without hesitation, specifically delays when 
transitioning from inspiration to rapid exhalation which can cause reductions in both peak 
expiratory flow (PEF) and FEV1 (D'Angelo et al., 1993). Finally, phase three, where 
continued encouragement is used so that the subject fully exhales. A sufficient 
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assessment is achieved when three tests are completed that are free from artefact, such 
as coughing, with FEV1 results no less than 0.15 L apart (ATS., 1999; Miller et al., 2005). 
 
A positive diagnosis of EIB is primarily achieved when FEV1 has a ≥10% reduction post 
provocation test when compared with a baseline measure (ATS., 1999), with severity of 
the EIB symptoms being measured through the FEV1 time curve (Anderson et al., 2010). 
Guidelines by the ATS. (1999) state that spirometry should be completed at baseline, 
then periodically post provocation test. Guidelines state appropriate post provocation 
testing should be completed at 5, 10, 15, 20, and 30 min, although earlier time points of 
1 and 3 min have been found to record lowest FEV1 due to severe EIB becoming present 
(Anderson et al., 1991; ATS., 1999). Research by Trumper et al. (2009) only sampled 
once at 10 min post-test, due to technical reasons. Although within reported range for 
greatest reduction in FEV1, it cannot be disputed that subjects may have been diagnosed 
negatively, due to the cessation of EIB occurring earlier or later than the 10 min test time. 
Similarly, Seear et al. (2005), completed spirometry at only 5 and 15 min post exercise, 
and out of the 52 children tested, only 8 were diagnosed with EIB, which, although not 
stated, could be down to the limited assessment. Wilber et al. (2000) research into the 
prevalence of EIB in Olympic athletes use time points of 5, 10 and 15 min, and even 
though it was not exact to the ATS guidelines, results remained similar to both Trumper 
et al. (2009) and Seear et al. (2005). Although positive results may be found when one 
or two time points are used post provocation test, individual variances may cause a shift 
in the time where fall in FEV1 is greatest (Anderson et al., 1991), so completion of more 
assessment will remove ambiguity and increase the validity within the data. Spirometry 
assessments up to 30 min post exercise has been recorded as the time of lowest FEV1 
(Brudno et al., 1994), and although ATS guidelines suggest recording up to 30 min, it 
remains controversial as a delay of such length is infrequently seen (ATS., 1999). 
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2.11 Standardisation 
Although research has been completed using the ECT, EVH and comparing both 
provocation tests, it has been brought into question whether the methods they had used 
were valid and reliable, and following the current guidelines. A review by Stickland et al. 
(2010) found that some previous research had failed to follow the current ECT guidelines, 
which could have affected the overall results. Out of nine studies, only one followed the 
current ATS guidelines, with deviations being; uncontrolled room temperature and 
relative humidity, no nose clip, duration was too long or graded exercise was used. For 
the four studies which looked to evaluate the ECT against the EVH, none of the studies 
followed the ATS guidelines, so the sensitivity of the EVH relative to the ECT is unclear. 
 
Alongside provocation method deviations, previous research has lacked adherence to 
the spirometry guidelines. Current ATS/ERS methods state that spirometry should be 
completed at 5,10,15,20 and 30 min post provocation test, with optional 1 and 3 min. Of 
the studies found, none of them completed spirometry at all-time points, ranging from 
one to three samples (Wilber et al., 2000; Rundell et al., 2004; Seear et al., 2005; 
Dickinson et al., 2006; Trumper et al., 2009). Although it has been stated that peak fall 
in FEV1 occurs between 5-12 min (Anderson, 2011), the physical variances between 
individuals and response to provocation tests could affect the onset of EIB, causing an 
under or over diagnosis. 
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3.1 Participants 
Twenty-two participants initially volunteered to participate in this study. Four participants 
were unable to complete all of the trials due to injury and a fifth was removed from the 
trial by the investigator due to a severe airway response to the ECT, with a FEV1 fall of 
49%. The remaining seventeen participants (mean (SD) age 25.2 (5.1) yr, stature 1.81 
(.06) m, mass 85.4 (13.7) kg), were either University level athletes, who competed in a 
variety of British Universities & Colleges Sport (BUCS) leagues (n=10; 9 male, 1 female), 
or were professional rugby league players (n=7 male). Three of the participants had a 
prior history of asthma of which two were professional rugby league players. Research 
was completed in accordance with the University of Gloucestershire regulations and the 
Universities Ethical Committee. Prior to testing, all participants were required to complete 
a health history questionnaire and a questionnaire to identify any potential 
contraindications to inhaled salbutamol, and to provide informed consent. By the 
recommendations of Anderson et al (2010), prior to any testing participants with a pre-
diagnosed history of asthma were asked to withhold medication (Short-acting β2-agonist 
8 hr, long-acting β2-agonist 24 hr). Participants were, however, instructed to use their 
medication if required and to inform the study investigator so that testing could be 
rescheduled. A short-acting β2-agonist (100 mcg salbutamol) was available to 
participants at all times to offer immediate relief if required. All participants completed 
testing of their own free will and could stop at any point with no repercussions. 
 
3.2 Procedures 
In a repeated measures design participants visited the laboratory on two occasions. At 
each visit participants first completed baseline spirometry followed by either a randomly 
assigned ECT or EVH test. Immediately following the provocation test participants 
performed follow-up spirometry to assess the effect of the provocation test on lung 
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function. Participants attended the laboratory in their usual exercise clothing and 
footwear and were asked to maintain similar dietary habits for each visit. In addition to 
withholding medication, participants were requested to avoid caffeine and strenuous 
exercise for 12 hr prior to each visit (Anderson et al. 2010). 
 
3.3 Spirometry 
Spirometry was performed in accordance with ATS/ERS guidelines (Miller, Hankinson et 
al. 2005) using an electronic flow measurement spirometer (Microloop, Micromedical, 
Rochester, Kent, UK) connected to a PC running dedicated software (SPCS, 
Micromedical, Rochester, Kent, UK). Prior to each test a verbal and visual demonstration 
was provided. For each manoeuvre, a maximal forced exhalation procedure was 
performed in a seated position, with the participant wearing a nose clip. Participants 
began with two to three tidal breaths before fully inhaling, followed immediately with a 
maximal forced exhalation with limited delay. Verbal encouragement was given during 
exhalation to encourage maximal effort and to ensure exhalation was complete. 
 
At each visit to the laboratory, and prior to each provocation test participants’ baseline 
lung function was measured. Lung function was also assessed immediately post-test 
and at 0, 3, 5, 10, 15, 20 and 30 min. At baseline a minimum of three acceptable FVC 
manoeuvres (maximum of 8) were performed. On completion of three acceptable tests 
the results were assessed for reproducibility. Specifically, if the difference between the 
highest and next highest FEV1 and FVC was ≤ 0.15 L. The largest FVC and FEV1 were 
selected from all the useable tests with other indices such as PEF and FEV1/FVC, 
derived from the test with the largest sum of FVC and FEV1. For the post provocation 
tests, spirometry was performed in duplicate with each test approximately 30 s apart, 
with the best test being used to assess fall in FEV1  
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3.4 Exercise Challenge Test 
The ECT protocol followed current ATS guidelines. Each test was performed on a 
motorised treadmill (ELG 55, Woodway, Gmbh, Weil am Rhein, Germany) within an 
environmental chamber (9388 Athlete Training Room, Sanyo Gallenkamp PLC, 
Loughborough, UK) at an ambient temperature of 8 ˚C. This temperature assumed that 
the water content of the inspired air was < 10 mg·L-1. Temperature and humidity was 
continuously monitored by a temperature and humidity probe (RHT-G-Z5-0, Grant 
Instruments, Cambridge, UK), which sampled from the centre of the chamber and was 
interfaced to a Squirrel SQ2020 data logger (Grant Instruments, Cambridge, UK).  
 
The protocol design was chosen to produce 4-6 min of high-intensity exercise with a total 
duration of 6-8 min (ATS., 1999). Over the first 2 min the treadmill speed and gradient 
were rapidly increased until the target HR was achieved. Once target HR had been 
reached the participants completed 4-6 min of continuous exercise, with treadmill speed 
and gradient adjusted to maintain target HR. HR was recorded via chest heart rate 
monitor (RCX5, Polar Electro Oy, Kempele, Finland) recording data every 5 s and 
monitored throughout to ensure HR was within the target zone. 
 
3.5 Eucapnic Voluntary Hyperpnoea 
The EVH test was conducted following the recommendations of the IOC-MC (Anderson, 
Argyros, Magnussen & Holzer, 2001). All tests were performed using the EucapSys™ 
EVH system (SMTEC SA, Nyon, Switzerland). Participants inhaled a medical grade dry 
gas mixture of 5% CO2 and 21% O2 via a face mask connected to the EVH system via 
flexible tubing. Participants were instructed to hyperventilate at a rate equivalent to 30 
times baseline FEV1 for 6 min (Anderson, Argyros et al. 2001). Throughout the test, 
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visual and verbal feedback was provided to encourage the participant to maintain V̇E at 
the target rate. 
 
3.6 Treatment of Data 
Raw spirometry and HR data was exported into Excel. At each time point FEV1, FVC, 
PEF and FEV1/FVC were recorded into individual spreadsheets. Predicated values for 
target HR and target ventilation were calculated in Excel. For the ECT, target HR was 
calculated via (220 - Age in yr) x 0.85. The target ventilation needed for the EVH was 
calculated prior via (Baseline FEV1 x 30). For diagnosis of EIB, a fall in FEV1 of ≥10% 
from baseline must be observed, calculated via: 
 
 
 
3.7 Statistical Analysis 
Descriptive data are reported as means and standard deviation (Mean (SD)). Statistical 
analysis was completed on SPSS (version 22, IBM, Armock: NY, United States) with an 
α value of p<0.05. Data was analysed for normality and found to be normally distributed. 
A series of individual paired samples t-tests were performed to compare baseline FEV1, 
FVC, PEF and FEV1/FVC for both positive and negative results. A series of individual 
paired samples t-tests were performed to compare predicted FEV1, FVC, PEF and 
FEV1/FVC for both positive and negative results. A paired samples t-test was performed 
comparing target HR achieved during the ECT for positive and negative results. A paired 
samples t-test was performed comparing target V̇e achieved during the EVH for positive 
and negative results. A series Individual paired samples t-test were performed to 
compare the peak delta (Δ) in FEV1peak, FVCpeak PEFpeak, and FEV1/FVCpeak during the 
ECT and EVH. A series of repeated measures 2-way analysis of variance (ANOVA) were 
(FEV1post – FEV1baseline) 
 FEV1baseline 
 
X 100 
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performed to determine whether differences were present at each post provocation time-
point between percentage Δ in FEV1, FVC, PEF, and FEV1/FVC for both the ECT and 
EVH tests. If a significant difference was present, follow up Bonferroni paired samples t-
tests were performed to determine whether differences were present at each post 
provocation time-point (0, 3, 5, 10, 15, 20, and 30) for the ECT and EVH. A Bland and 
Altman plot was produced to evaluate limits of agreement between the lowest %ΔFEV1. 
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4.1 Summary 
All seventeen participants completed both of the provocation tests. As seen in Table 1, 
nine had a positive response (those highlighted) to at least one of the challenges based 
with a fall in FEV1 ≥10%. Out of those, five experienced a ≥10% fall in both the ECT and 
EVH, with two during the ECT and two during the EVH alone. For the following analysis 
all seventeen participants were included unless otherwise stated. 
Table 1: Participant response to provocation testing 
Participant Baseline FEV1 (L) Predicted FEV1 (%) ECT ΔFEV1 (%) EVH ΔFEV1 (%) 
1 4.36 103 -5 1 
2 5.02 111 -10 -8 
3† 3.83 83 -9 -7 
4* 3.67 100 -13 -26 
5†* 5.00 98 -4 -4 
6 4.53 101 -1 -4 
7† 4.81 103 1 -7 
8 4.45 111 -11 -7 
9 4.34 110 -7 -10 
10†* 4.13 92 -16 -28 
11 4.57 94 -29 -26 
12† 4.76 102 -4 -8 
13† 5.32 104 -23 -23 
14 4.52 103 -5 -14 
15† 5.07 103 -2 -2 
16 3.94 90 2 -6 
17 5.20 121 -16 -11 
Mean (SD) 4.56 (0.48) 102 (8.96) -8.99 (8.35) -11.19 (9.11) 
* Past history of Asthma. † Professional Rugby League Players 
Participants with positive responses for EIB are highlighted in bold and greyed. 
ΔFEV1 values rounded to nearest whole number 
Baseline FEV1 taken from second visit. 
 
4.2 Baseline Lung Function 
All participants had a baseline FEV1 that was >75% of the predicted value and an 
FEV1/FVC >70%. Consequently, all participants were considered to be free of an airway 
obstruction at rest and suitable for testing. Actual and predicted values for FEV1, FVC, 
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PEF and FEV1/FVC and FEF25-75%, were not significantly different between EIB positive 
and EIB negative participants. There was a significant difference in percent predicted 
FVC between EIB positive and negative participants (p=0.048) but no differences in any 
of the other percent predicted parameters. 
 
4.3 Achievement of Target Heart Rate during the Exercise Challenge Test 
There was no significant difference in percentage of target HR achieved during the 
exercise challenge test between the ECT positive and negative participants (102 ± 2% 
vs 100 ± 2%; p=0.20). The HR that was achieved by all participants during the ECT 
ranged from 96 to 104% of the target HR (Figure 1). 
 
Figure 1: Percentage of target HR achieved against peak fall in FEV1 
 
4.4 Achievement of Target Ventilation during the Eucapnic Voluntary Hyperpnoea 
There was no significant difference in the percentage of target V̇E achieved during EVH 
between EVH positive and negative participants (91 ± 4.8% vs 87.6 ± 72%; p=0.29). The 
percentage of target MVV achieved during the EVH ranged from 79 to 99%. All 
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participants achieved a level of V̇E greater than 21 times FEV1 (range 23.6 – 29.4 x 
FEV1), which is considered to be the minimum rate for a test to be considered valid 
(Brummel et al., 2009). Due to missing data on mean ventilation, three participants were 
not represented in Figure 2. 
 
Figure 2: Percentage of target V̇E achieved against peak fall in FEV1 
 
4.5 Effect of Provocation Test on the Airway Response: ECT and EVH 
There were no significant differences between the provocation tests for ΔFEV1peak 
(p=0.143, MD = 2.20, 95% CI 0.83 - 5.22, ΔFVCpeak (p=0.291, MD = -1.14, 95% CI 3.34 
- 1.07), or ΔPEFpeak (p=0.300, MD = 2.14, 95% CI -2.09 - 6.36). However, ΔFEV1/FVCpeak 
was significantly lower in the EVH compared to the ECT (p=0.018, MD = 5.04, 95% CI 
0.97 - 9.11) (Table 2). 
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Table 2: Mean (SD) for paired samples t-tests for peak fall in: ΔFEV1, ΔFVC, ΔPEF, and 
ΔFEV1/FVC. 
ΔFEV1peak (%) ΔFVCpeak (%) ΔPEFpeak (%) ΔFEV1/FVCpeak (%)* 
ECT EVH ECT EVH ECT EVH ECT EVH 
-8.99 -11.19 -3.98 -2.85 -8.72 -10.86 -3.62 -8.66 
(8.35) (9.11) ±(5.09) ±(3.43) (9.05) (9.62) (5.58) (8.18) 
* Significant difference (p≤0.005) between ECT and EVH 
Mean and standard deviation as; M (SD) 
 
4.6 Effect of Provocation Test on the Airway Response: Positive and Negative 
A series of paired samples t-tests were conducted to determine whether was were 
significant differences between the positive and negative results for both the ECT and 
EVH for the dependent variables: ΔFEV1peak, ΔFVCpeak, ΔPEFpeak and ΔFEV1/FVCpeak 
(table 3). Significant differences occurred between the positive and negative results for 
both the ECT and EVH for ΔFEV1peak (ECT p≤0.001 and EVH p≤0.001), ΔFVCpeak (ECT 
p≤0.001 and EVH p=0.05) and ΔFEV1/FVCpeak (ECT p=0.01 and EVH p=0.02). For 
ΔPEFpeak, significant difference occurred within EVH (p≤0.001) but not for ECT (p=0.27). 
 
Table 3: Mean (SD) for the paired samples t-tests in positive and negative results peak fall in 
ΔFEV1, ΔFVC, ΔPEF, and ΔFEV1/FVC. 
  n ΔFEV1peak (%)*˟ ΔFVCpeak (%)*˟ ΔFEV1/FVCpeak (%)*˟ ΔPEFpeak (%)˟ 
ECT 
+ 7 -16.81 (6.85) -8.03 (3.88) -15.14 (9.59) -5.47 (8.23) 
- 10 -3.52 (3.44) -1.16 (3.80) -4.23 (5.45) -2.32 (2.40) 
       
EVH 
+ 7 -19.78 (7.93) -4.76 (3.90) -16.96 (9.06) -15.65 (8.46) 
- 10 -5.17 (2.79) -1.51 (2.45) -6.59 (7.78) -3.77 (2.60) 
*Significant difference between positive and negative means for ECT. 
˟ Significant difference between positive and negative means for EVH. 
Mean and standard deviation as; M (SD) 
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4.7 Post Provocation Lung Function 
As seen in Table 4, a series of two-way repeated measures ANOVAs were used to 
determine possible differences for the main effects (provocation test and time) as well 
as the interaction (provocation test by time) for the dependent variables ΔFEV1, ΔFVC, 
ΔPEF and ΔFEV1/FVC across the seven post provocation test time-points (Post 0, Post 
3, Post 5, Post 10, Post 15, Post 20, Post 30). 
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Table 4: Mean (SD) for ΔFEV1, ΔFVC, ΔPEF and ΔFEV1/FVC over the seven post provocation 
test time points for positive and negative groups. 
ΔFEV1*˟ Post 0 Post 3 Post 5 Post 10 Post 15 Post 20 Post 30 
ECT 
+ 
-7.32 -11.79 -11.28 -11.10 -8.10 -7.73 -7.25 
(6.70) (7.62) (6.99) (7.47) (5.86) (6.83) (5.91) 
- 
-0.57 -1.67 -2.16 -1.98 -1.11 -0.75 -0.91 
(2.05) (3.37) (3.78) (3.59) (3.52) (3.30) (2.42) 
         
EVH 
+ 
-10.43 -15.64 -13.39 -10.95 -7.14 -7.72 -6.23 
(8.95) (9.27) (8.98) (7.57) (11.50) (5.05) (2.95) 
- 
-1.73 -3.97 -3.35 -0.12 -1.70 -1.60 -1.37 
(2.83) (3.51) (2.70) (6.83) (2.75) (2.96) (2.49) 
         
ΔFVC Post 0 Post 3 Post 5 Post 10 Post 15 Post 20 Post 30 
ECT 
+ 
-4.86 -3.57 -3.99 -3.07 -1.94 -2.46 -1.75 
(3.93) (3.52) (5.17) (3.83) (3.80) (3.32) (5.02) 
- 
-1.10 0.66 0.33 -0.55 0.27 0.28 -0.02 
(3.91) (3.81) (3.59) (4.36) (4.02) (4.04) (3.71) 
         
EVH 
+ 
-2.20 -3.48 -2.65 -1.86 -1.28 -1.18 -0.59 
(1.73) (2.90) (2.38) (2.75) (3.73) (2.68) (4.17) 
- 
0.42 -0.37 -0.75 -0.64 0.08 0.30 -0.45 
(1.99) (2.58) (2.44) (2.41) (3.37) (3.62) (2.36) 
         
ΔPEF Post 0 Post 3 Post 5 Post 10 Post 15 Post 20 Post 30 
ECT 
+ 
-7.00 -9.97 -9.34 -11.54 -10.36 -10.44 -8.85 
(9.88) (10.78) (9.80) (7.28) (7.22) (7.06) (7.75) 
- 
-3.45 -4.74 -2.35 -2.90 -4.34 -2.94 -3.17 
(4.38) (4.82) (6.26) (7.14) (5.92) (4.53) (5.26) 
         
EVH 
+ 
-9.59 -11.27 -11.21 -11.19 -14.08 -9.01 -6.46 
(10.71) (8.92) (10.65) (7.81) (8.59) (8.50) (8.14) 
- 
-5.99 -4.49 -3.90 -6.31 -4.47 -4.54 -3.15 
(6.76) (5.03) (5.72) (7.06) (4.77) (4.92) (7.30) 
         
ΔFEV1/FVC*˟ Post 0 Post 3 Post 5 Post 10 Post 15 Post 20 Post 30 
ECT 
+ 
-3.99 -5.36 -7.61 -8.25 -6.17 -5.21 -5.52 
(7.00) (6.72) (5.47) (6.30) (5.37) (6.13) (3.72) 
- 
1.18 -2.14 -2.15 -1.05 -0.95 -0.75 -0.41 
(3.37) (1.83) (2.51) (2.34) (2.07) (2.48) (2.84) 
         
EVH 
+ 
-8.60 -12.68 -10.98 -9.22 -8.21 -6.70 -5.52 
(8.46) (8.77) (8.24) (7.67) (6.49) (6.16) (3.48) 
- 
-2.12 -3.78 -2.60 -2.42 -1.65 -1.96 -0.91 
(3.56) (2.84) (2.02) (2.71) (2.57) (2.66) (2.88) 
* Significant interaction between the two provocation tests. 
˟ Significant main effect for time. 
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4.7.1 ΔFEV1 
The two-way repeated measures ANOVA for the dependent variable ΔFEV1 revealed a 
significant interaction between the two provocation tests (F(6,90)=2.261, p=0.044). Follow 
up post-hoc Bonferroni paired samples t-tests revealed no significant differences 
between the ECT and EVH at any of the seven time-points. A non-significant main effect 
was found for the provocation tests (F(1,15)=0.139, p=0.715), however there was a 
significant main effect for time (F(6,90)=5.167, p≤0.001). For the ECT test, follow up post-
hoc one-way repeated measures ANOVA revealed a significant difference over time 
(F(6,90)=3.629, p=0.003), with follow up Bonferroni tests showing no significant differences 
between all time-points. For the EVH test, a significant difference over time was found 
(F(6,90)=4.537, p≤0.001), with follow up Bonferroni revealing that post 0 min was 
significantly higher than post 3 min (MD=3.768, 95% CI=0.13-7.40) and post 3 min was 
significantly lower than post 20 min (MD=5.182, 95% CI=10.18-0.19). 
 
4.7.2 ΔFVC 
The two-way repeated measures ANOVA for the dependent variable ΔFVC revealed a 
non-significant interaction between the two provocation tests over time (F(6,90)=1.301, 
p=0.265). A non-significant main effect was found for the provocation tests (F(1,15)=0.323, 
p=0.578) as well as the main effect for time (F(6,90)=1.874, p=0.094). 
 
4.7.3 ΔPEF 
A two-way repeated measures ANOVA for the dependent variable ΔPEF revealed a non-
significant interaction between the two provocation tests over time (F(6,90)=0.706, 
p=0.646). A non-significant main effect was found for the provocation tests (F(1,15)=0.232, 
p=0.637) as well as the main effect for time (F(6,90)=1.732, p=0.123). 
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4.7.4 ΔFEV1/FVC 
A two-way repeated measures ANOVA for the dependent variable ΔFEV1/FVC revealed 
a significant interaction between the two provocation tests over time (F(6,90)=2.911, 
p=0.012). Follow up post-hoc Bonferroni paired samples t-tests revealed that the EVH 
test was significantly lower than the ECT at time-points 0 min (p=0.022, MD = 4.00, 95% 
CI 0.68 - 7.32) and 3 min (p=0.017, MD = 4.64, 95% CI 0.94 - 8.34). A non-significant 
main effect was found for the provocation tests (F(1,15)=2.598, p=0.128), however there 
was a significant main effect for time (F(6,90)=4.666, p≤0.001). For the ECT test, a follow 
up post-hoc one-way repeated measures ANOVA revealed a non-significant difference 
over time (F(6,90)=1.969, p=0.078). For the EVH, a significant difference over time was 
found (F(6,90)=7.900, p≤0.001), with follow up Bonferroni revealing that post 0 min was 
significantly higher than post 3 min (MD=2.874, 95% CI=0.034-5.74) and that post 3 min 
was significantly lower than both post 15 min (MD = -3.167, 95% CI 6.05 - 0.29) and post 
20 min (MD = -3.701, 95% CI 7.19 - 0.22). 
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4.8 Agreement between ECT and EVH 
 
Figure 3: Correlation between peak fall in FEV1 during the ECT and EVH. 
As expected a strong positive correlation (R=0.78) was found between the ΔFEV1 
responses to ECT and EVH. The line of identity provides an indication to the degree of 
spread amongst the data points, which would all lie along the line if agreement was 
perfect (figure 3). 
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Figure 4: Bland and Altman plot for the mean scores and difference in peak for FEV1 
between the ECT and EVH. 
 
The mean difference is 2.2% indicating that ECT tended to give a ΔFEV1 reading 
between 0.8% lower and 5% higher than EVH. The upper and lower limits of agreement 
(13.7 and -9.3% respectively) were large indicating that the ECT may result in a ΔFEV1 
between 13.7% higher and 9.3% lower than EVH. Furthermore, the confidence intervals 
for the upper and lower limit of agreement (8.5 to 18.6% and -14.5 to -4.4% respectively) 
are wide also indicating poor agreement (figure 4). 
 
 
-15%
-10%
-5%
0%
5%
10%
15%
-30%-25%-20%-15%-10%-5%0%
D
if
fe
re
n
c
e
 i
n
 Δ
F
E
V
1
p
e
a
k
s
c
o
re
s
 
(L
·s
-1
) 
F
o
r 
E
C
T
 a
n
d
 E
V
H
Mean Scores for ΔFEV1 (%) between ECT and EVH
Chapter Five - Discussion  MSc by Research 
48 
 
 
 
 
 
 
 
 
 
CHAPTER FIVE 
  
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
Chapter Five - Discussion  MSc by Research 
49 
 
 
5.1 Key Findings 
The main findings of our study found that out of seventeen participants who completed 
both provocation tests, nine experienced a ≥10% fall in FEV1. Five experienced a fall of 
≥10% in both the ECT and EVH, with two in the ECT or EVH alone. Out of the nine, only 
two had a previous history of asthma, with our screening identifying seven who had no 
previous respiratory issues. Our study suggests that athletes need to be tested for EIB, 
regardless if a history of asthma is present or not. Our results, although varied from 
previous research, may be inconclusive due to limitations (Dickinson et al., 2006; 
Trumper et al., 2009; Castricum et al., 2010). 
 
5.2 Literature Comparison 
The object of the present study was to follow the recommendations of Stickland et al. 
(2010), which called for the need to standardise the methods employed during the 
screening process within research, specifically with the control of inspired air water 
content, spirometry and intensity. The methods used during the study followed that of 
the current ATS guidelines for ECT and current methods for the EVH (ATS., 1999; 
Anderson et al., 2001). Above the guidelines, ECT testing was performed within an 
environmental chamber to control air temperature to reduce air water content, and 
spirometry was completed with increased post provocation test sampling times. 
 
Our research found that there was no significant difference between the ECT and EVH 
when performing them following the standardised guidelines. Out of the seventeen 
participants who completed both provocation tests, nine experienced a fall of ≥10% in 
FEV1. Five of those had ≥10% falls in both the ECT and EVH, with two in the ECT and 
EVH alone. Our results showed that, if performed using current guidelines, both the ECT 
Chapter Five - Discussion  MSc by Research 
50 
 
and EVH are sufficient tests for inducing the EIB response in athletes. The results of this 
study go against previous research (Rundell et al., 2004; Dickinson et al., 2006; Trumper 
et al., 2009), which has stated that the EVH was conclusively the more sensitive test 
when compared to the ECT (Rundell et al., 2004; Dickinson et al., 2006; Castricum et 
al., 2010). 
 
Trumper et al. (2009) research suggested that the ECT was not sufficient for the 
assessment of EIB. This is due to the predicted HR formula used for the target exercise 
intensity does not put the body in a state of anaerobic exercise for exercise bronchial 
provocation. This variance, specifically in the athletic population, could be due to physical 
fitness or participants sporting event. When comparing the two methods, Dickinson et al. 
(2006) found a greater number of positive EIB assessments during the EVH, stating that 
this is due to the greater amount of control compared to the ECT. Although we used the 
predicted HR formula to follow the current ATS guidelines, we focused control of the ECT 
by controlling the inspired air temperature to reduce the inspired water content. The aim 
of our research was to assess EIB via ECT and EVH protocols following the standardised 
methods. 
 
5.3 Pathological Interpretation 
The variations from previous research would coincide with the review of Stickland et al. 
(2010) with the lack of adherence to the current guidelines causing a possible under or 
over estimation of the results. As stated, the key areas which previous research had 
failed to control was the inspired air water content, exercise intensity and spirometry. 
 
Environmental conditions during the ECT may be the contributing factor when comparing 
the difference in results. Dickinson et al. (2006) stated that the key factors for the EVH 
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tests superiority was the level of control over the inspired air water content and V̇E. 
Ensuring that the inspired air is sufficiently dry would stimulate the osmotic hypothesis 
for the mechanisms of EIB, causing water to move from nearby cells to condition the 
inspired air (Anderson & Daviskas, 1997). From our results, increasing control over 
inspired air water content can be completed by performing the ECT in an environmental 
chamber set at 8˚C. When comparing our results to Dickinson et al. (2006) and 
Castricum et al. (2010), who performed the ECT in 18˚C, 46% RH and 21˚C,  60.5 RH 
respectively, our results suggest that completing the ECT in 8˚C creates an environment 
with sufficiently low air water content to stimulate the osmotic mechanisms of EIB. The 
movement from 8˚C during the ECT to 20˚C during post spirometry may have assisted 
in the rewarming of the airway, aiding to the fall in FEV1. The range in temperature if not 
as large as those where rapid rewarming occurs (McFadden et al., 1986), suggesting 
that it was unlikely that any thermal mechanisms affected the fall in FEV1. Consideration 
must be made into the accessibility of environmental chambers or systems which can 
control environmental conditions such as temperature and air water content. Although 
controlling temperature and air water content has a direct effect on the stimulation of EIB, 
more research would have to be done to fully ensure that controlling temperature and 
water content should be standard in testing. 
 
Control of V̇E was also a key factor for the superiority of the EVH (Dickinson et al., 2006). 
During the ECT, target HR ranged between 96 to 104% 85% HRmax, with EVH target V̇E 
ranged between 79 to 99% 80% MVV. From our data, the ECT had much greater control 
of target HR compared to target ventilation for EVH. The lack of control comes down to 
the EVH being a voluntary action compared to a treadmill protocol. Although all the 
participants achieved a level of ventilation over the minimum rate of 21 times FEV1 
(Brummel et al., 2009), the failure of participants achieving the target 30 times FEV1 may 
have caused an under diagnosis in the EVH results. Although target HR during the ECT 
was controlled, it does not take into account the V̇E during testing. Research by Trumper 
Chapter Five - Discussion  MSc by Research 
52 
 
et al. (2009) cast doubt on the HR based protocol for the ECT. Trumper et al. (2009)  
concluded that using a percent predicted HR ECT does not allow for the physical 
variances seen within the athletic population. Although the ATS state that 80 to 90% 
HRmax protocol is sufficient to induce 40 to 60% MVV, physical variances may affect 
these ratios. 
 
Spirometry remains a key part of the screening process, and an area in which previous 
research has failed to follow current guidelines (Stickland et al., 2010). Our results found 
that peak falls in FEV1 ranged throughout the sample times emphasising the need to 
sample regularly. Slightly askew from the current guidelines, the most peak falls post 
EVH occurred after 3 min, which is currently an optional time point suggested by the ATS 
(ATS., 1999).  
 
5.4 Clinical Interpretation 
With the high prevalence of EIB in the athletic population, it still remains important to 
screen even those who have no previous history of asthma. Out of the seventeen 
participants screened, 53% achieved a fall in FEV1 ≥10%. Our results suggest that both 
the ECT and EVH are sensitive enough tests for stimulating the EIB response, as long 
as both are performed under the right conditions. 
 
Trumper et al. (2009) suggests that determining an individual’s aerobic capacity should 
be achieved prior to the ECT. Completing this would add an extra step to the current 
simple screening process, but would create a more accurate ECT as pre-determined 
exercise intensity would already be known. From our data, this step would not be 
required for general screening, but for elite athletes, it may provide more accuracy during 
the screening process. 
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5.5 Strengths, Limitations and Future Research 
The key strength of this research was the testing standards. As suggested by Stickland 
et al. (2010), a key criticism of previous research was the need to standardise the 
methods when screening athletes. In this study, all tests were performed to a high 
standard following the current ATS guidelines for the ECT and the guidelines for EVH 
(ATS., 1999). Previous research also failed to follow the standards for spirometry (Wilber 
et al., 2000; Rundell et al., 2004; Dickinson et al., 2006; Trumper et al., 2009). This study 
address this by completing the standard model with two extra sample times at 0 and 3 
min post provocation test. During EVH tests, 10 out of the 17 participants experienced 
their peak fall in FEV1 at 3 min post, implying the need to perform spirometry earlier than 
the recommended 5 min post. 
 
Our research had some limiting factors. The main factor was the participant number. 
During the study, participant recruitment was restricted by the number of University level 
athletes interested in the study. A larger sample size would be more create a greater 
image of the current condition of EIB in University level athletes, but also strengthen the 
data analysis. A larger sample may find a different result compared to our research. 
 
Future research following the practice employed in this study should look to increase the 
sample size to strengthen the data. Although our data was sufficient, a greater number 
of participants would allow for a more accurate analysis. Measuring the air water content 
during the ECT would give a definitive answer to determine whether the environmental 
conditions matched that seen in the EVH. Although RH can be controlled using an 
environmental chamber, literature states a temperature of <10˚C is sufficiently dry 
(Anderson, 2011). Finally, due to software issue we were unable to get the forced 
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expiratory flow (FEF25-75) values during spirometry. Although not a direct measure of EIB, 
more respiratory values would have added to the data sets. Overall, the areas for future 
research should not have caused false readings within our results. 
 
Although the results of our study are different to those found in previous research, some 
limitations must be considered. The conditions that the ECT was performed in were 
specifically designed to stimulate the EIB response, rather than related to a sports 
specific format. The ability to control air temperature 
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In summation, the current study aimed to determine whether there was a significant 
difference between the ECT and EVH when testing athletes following current guidelines. 
Out of the 17 participants who completed both tests, nine experienced a fall ≥10%, 
suggesting the presence of EIB. When comparing peak falls in FEV1 achieved during the 
ECT and EVH, there was no significant difference, which suggests that both methods 
can be used when testing athletes for EIB. However, our Bland and Altman plot revealed 
poor agreement, meaning limitation of our study may mean our results are more 
inconclusive.  
 
Future research needs to develop on from the model used within this study by increase 
the size of the participants tested to strengthen the data set. Although we found a 
significant difference between the ECT and EVH for ΔFEV1 across the post-test 
spirometry, a larger sample size may provide a clearer answer to the research aims. 
 
Data collection of V̇e during the ECT may also provide an added perspective on the 
ventilation achieved compared to the target HR, as it does not allow for physical 
variances which may occur in high level athletes. Pre testing for HR would add an 
addition step but also give an accurate target HR for the ECT. 
 
The aim of the study was to compare the ECT and EVH when following current 
guidelines. From our results, we cannot conclude whether the ECT or EVH is a more 
superior test. Although we found a significant difference between the ECT and EVH for 
FEV1 across the post-test spirometry, peak FEV1 had no significant difference, and with 
poor agreement, our results remain inconclusive due to limitations of the study. 
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Appendix 8.1 – Health History Questionnaire 
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Appendix 8.2 – Respiratory Clinic Health Questionnaire 
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Appendix 8.3 – Research Participant Information Sheet 
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Appendix 8.4 – Medication Withhold Times 
 
